Business Wire

Quidel’s Sofia® SARS Antigen Test Receives Emergency Use Authorization for Screening Use With Serial Testing

SAN DIEGO--(BUSINESS WIRE)--Quidel Corporation (NASDAQ: QDEL) (“Quidel”), a leading provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems, ...
Business Wire

Quidel Receives FDA Clearance and CLIA Waiver for Its Point-of-Care Sofia® 2 Immunoassay Analyzer for Use with Sofia Influenza A+B Assay

SAN DIEGO--(BUSINESS WIRE)--Quidel Corporation (NASDAQ: QDEL), a provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems, announced today it has ...
Nasdaq

Quidel Receives Amended Emergency Use Authorization for New Sofia® Q Rapid Antigen Test Device

Quidel plans initial release to professional and point-of-care segments with a goal of expansion to serve telemedicine and home markets Sofia Q is the latest product in Quidel’s best-selling Sofia ...
Benzinga.com

How to Trade Quidel's Massive Breakout

) are screaming higher this afternoon after the company announced that it had received clearance from the FDA to sell its Sofia Analyzer and its Sofia A+B FIA. Currently, shares are higher by 13.21%, ...
Reuters

Quidel receives FDA clearance for its point-of-care Sofia® Lyme FIA

China said on Saturday "the market has spoken" in rejecting U.S. President Donald Trump's tariffs, and called on Washington for "equal-footed consultation" after global markets plunged in reaction to ...